The oral thin films market is experiencing significant growth due to several key factors. Firstly, the rising demand for convenient and patient-friendly drug delivery systems has driven the adoption of oral thin films. These films offer advantages such as ease of administration, rapid disintegration, and precise dosing. Secondly, the expanding geriatric population and the increasing prevalence of chronic diseases have fueled the demand for innovative pharmaceutical solutions. Additionally, advancements in technology and manufacturing processes have led to the development of improved oral thin film formulations, enhancing their efficacy and safety. Moreover, the growing focus on personalized medicine and the surge in research and development activities are driving market expansion. Overall, the oral thin films market is poised for continued growth due to its numerous advantages and increasing demand for innovative drug delivery systems.
The global Oral Thin Films Market was valued at US$ 2,450.6 Mn in 2021 and is forecast to reach a value of US$ 4,379.9 Mn by 2028 at a CAGR of 8.7% between 2022 and 2028.
Major Players in the Oral Thin Films Industry:
1. C L Pharm
C L Pharm is a pharmaceutical company that specializes in the development and manufacturing of oral thin films. The company was founded in 1996 and is headquartered in China. It operates in multiple countries worldwide, including the United States, Europe, and Asia. However, there is no specific recent development available for C L Pharm in the field of oral thin films.
2. Cure Pharmaceutical
Cure Pharmaceutical is a leading drug delivery and development company that focuses on the oral thin film technology platform. It was founded in 2011 and is based in Oxnard, California. Cure Pharmaceutical operates in several countries globally, including the United States, Canada, and Mexico. In October 2022, Cure Pharmaceutical announced a partnership with Canna World Market to develop and distribute hemp-infused oral thin films, expanding its product portfolio in the field.
3. Sunovion Pharmaceuticals Inc.
Sunovion Pharmaceuticals Inc. is a biopharmaceutical company that develops and commercializes innovative therapies for people with serious medical conditions. Although Sunovion Pharmaceuticals Inc. has a diverse product portfolio, there is no specific recent development available regarding oral thin films. The company was founded in 1984 and is headquartered in Marlborough, Massachusetts. Sunovion Pharmaceuticals Inc. operates in multiple countries worldwide, including the United States, Japan, and several European countries.
4. ZIM Laboratories Limited
ZIM Laboratories Limited is an Indian pharmaceutical company that specializes in developing and manufacturing oral thin films. It was founded in 1989 and is headquartered in Nagpur, India. ZIM Laboratories operates in various countries, including India, the United States, and several countries in Europe and Africa. In March 2023, ZIM Laboratories announced the launch of a new oral thin film product, expanding its portfolio in the field of drug delivery.
5. NAL Pharma
NAL Pharma is a Canadian pharmaceutical company that focuses on the development and manufacturing of oral thin films. The company was founded in 2016 and is based in Quebec, Canada. NAL Pharma operates primarily in Canada and is dedicated to advancing the field of oral thin film technology.
6. Viatris
Viatris is a global pharmaceutical company formed through a merger between Mylan N.V. and Pfizer's Upjohn division. Although Viatris has a diverse product portfolio, there is no specific recent development available regarding oral thin films. The company was founded in 2020 and is headquartered in Canonsburg, Pennsylvania. Viatris operates in numerous countries worldwide, including the United States, Europe, and Asia.
7. LTS Lohmann Therapie-Systeme AG
LTS Lohmann Therapie-Systeme AG is a German pharmaceutical company that specializes in transdermal drug delivery systems. While the company focuses on transdermal patches, there is no specific recent development available for LTS Lohmann Therapie-Systeme AG in the field of oral thin films. It was founded in 1984 and is headquartered in Andernach, Germany. LTS Lohmann Therapie-Systeme AG operates in multiple countries worldwide.
8. IntelGenx Corp.
IntelGenx Corp. is a Canadian pharmaceutical company that develops and manufactures innovative oral thin film products. The company was founded in 2003 and is based in Montreal, Canada. IntelGenx Corp. operates primarily in Canada and the United States. In April 2023, IntelGenx Corp. announced a collaboration with an undisclosed pharmaceutical company for the development and commercialization of an oral thin film product, marking a significant recent development in the field.
Definition- Oral thin films are flexible, solid dosage forms that dissolve rapidly in the mouth to deliver medication. They are typically made from a polymer matrix and offer a convenient and discreet alternative to traditional tablets or capsules.
